Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 793 results: Page 1 of 32


Tier Species Size Attr. GeneSet
Tier I 11 GS269538: GWAS Catalog Data for alcohol and nicotine codependence in 818 European ancestry cases, 1,396 European ancestry controls, 449 African American cases, 480 African American controls
Tier II 7530 GS236751: [MeSH] Polymorphism, Single Nucleotide : D020641
Tier II 563 GS237186: [MeSH] Chemically-Induced Disorders : D064419
Tier II 6978 GS237257: [MeSH] Pathologic Processes : D010335
Tier II 192 GS237364: [MeSH] Alcohol-Related Disorders : D019973
Tier II 2022 GS237733: [MeSH] Mental Disorders : D001523
Tier II 7989 GS238111: [MeSH] Genotype : D005838
Tier II 20142 GS241072: [MeSH] Genetic Phenomena : D055614
Tier II 7330 GS241292: [MeSH] Pathological Conditions, Signs and Symptoms : D013568
Tier II 5560 GS241654: [MeSH] Disease Attributes : D020969
Tier II 14069 GS241850: [MeSH] Genetic Variation : D014644
Tier II 165 GS242550: [MeSH] Alcoholism : D000437
Tier II 7959 GS242870: [MeSH] Polymorphism, Genetic : D011110
Tier II 5141 GS243775: [MeSH] Genetic Predisposition to Disease : D020022
Tier II 433 GS244151: [MeSH] Substance-Related Disorders : D019966
Tier II 5153 GS244797: [MeSH] Disease Susceptibility : D004198
Tier I 5 GS270153: GWAS Catalog Data for alcohol dependence in 1,409 European ancestry cases, 1,518 European ancestry controls, 681 African American cases, 508 African American controls
Tier III 17420 GS400133: Transcriptome of the human dorsolateral prefrontal cortex of people with a history of cocaine use vs control (RNA-seq)
Tier III 26035 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier III 23331 GS407951: Differentially expressed genes in humans dorsolateral prefrontal cortex associated with opioid use disorder_qvalue
Tier IV 3693 GS408178: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, log2FC
Tier IV 3693 GS408179: Differential gene expression comparison between Carnegie Stages (CS) 14 and 17 during human embryo craniofacial development, Adj-P value
Tier IV 1186 GS408181: Differential gene expression comparison between Carnegie Stages (CS) 15 and 17 during human embryo craniofacial development, Adj-P value
Tier IV 9363 GS408183: Differential gene expression comparison between Carnegie Stages (CS) 15 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC